Visual Restoration for Hemianopia
Status: | Recruiting |
---|---|
Healthy: | No |
Age Range: | 21 - 75 |
Updated: | 3/2/2019 |
Start Date: | March 15, 2018 |
End Date: | May 1, 2019 |
Contact: | Lisa Blanchard |
Email: | lisa_blanchard@urmc.rochester.edu |
Phone: | 585-276-5425 |
The purpose of this research is to assess the efficacy of a visual training task on reducing
the size of a visual field deficit caused by brain damage in adults, and its ability to
improve visual functions in this patient population.
the size of a visual field deficit caused by brain damage in adults, and its ability to
improve visual functions in this patient population.
Inclusion Criteria:
- Ages 21-75 years old
- Ability and willingness to sign informed consent
- Willingness to participate in both the training and evaluation sessions
- MRI or CT scan demonstrating lesion in the occipital lobe of the brain and/or
affecting white matter tracts that provide visual input to the occipital lobe of the
brain
- Brain injury due to ischemic or hemorrhagic causes that occurs after age 18 and at
least 90 days prior to screening visit
- At least two reliable HVF's demonstrating good fixation and a stable homonymous
incomplete (e.g., quadrantanopia or relative defect) or complete hemianopia
- Reliable HVFs with repeat HVFs if randomization takes place more than 4 weeks after
screening visit
- A homonymous, contiguous visual deficit measured by the 24-2 HVF to be a minimum of
two testing locations high and two testing locations wide, where impaired locations
are any that measure a threshold of less than 15 dB.
- Demonstration of good fixation on visual training task - able to fixate the small
targets presented as fixation letters reliably for 1000ms with jitter over less than 1
degree of visual angle in any direction away from target edge
Exclusion Criteria:
- Physical, neurological or mental disability that would interfere with study
intervention
- Concurrent participation in "vision therapy" other than standard occupational or
physical therapy
- Unreliable visual fields on prior testing, indicated by greater than 20% fixation
losses, false positives, or false negatives.
- Inability to discontinue medications judged to affect training and/or assessment
(e.g., Ritalin, amphetamines, dopamines, or chemotherapeutic agents)
- Physical condition likely to preclude completion of the clinical trial (e.g. end-stage
or uncontrolled cancer, uncontrolled epilepsy, or end-stage heart disease)
- Ocular or neurological condition that would interfere with training or assessment
(e.g. damage to the optic nerves or lateral geniculate nucleus, any degenerative
ocular condition)
- Best corrected vision worse than 20/40
- Impaired foveal Humphrey sensitivity as indicated by the HVF tests.
- Presence of vision loss resulting from ocular disease or disorder
- Presence of bilateral visual acuity loss from any source
- Inability to demonstrate fixation stability on eye movement monitored testing
- Inability to follow training instructions
We found this trial at
3
sites
900 Northwest 17th Street
Miami, Florida 33136
Miami, Florida 33136
Phone: 305-326-6021
Click here to add this to my saved trials
Click here to add this to my saved trials
210 Crittenden Boulevard
Rochester, New York 14642
Rochester, New York 14642
Phone: 585-276-5425
Click here to add this to my saved trials